Literature DB >> 31977039

Co-occurrence of DNMT3A, NPM1, FLT3 mutations identifies a subset of acute myeloid leukemia with adverse prognosis.

Matheus F Bezerra1,2, Aleide S Lima3, Maria-Riera Piqué-Borràs4, Douglas R Silveira5,6, Juan L Coelho-Silva3,7, Diego A Pereira-Martins3,7, Isabel Weinhäuser7, Pedro L Franca-Neto3, Lynn Quek8,9, Anna Corby9, Mayara M Oliveira3, Marinus M Lima3, Reijane A de Assis10, Paula de Melo Campos11, Bruno K Duarte11,12, Israel Bendit5, Vanderson Rocha5, Eduardo M Rego5, Fabiola Traina7, Sara T Saad11,12, Eduardo I Beltrão13, Marcos A Bezerra3, Antonio R Lucena-Araujo3.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 31977039     DOI: 10.1182/blood.2019003339

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  13 in total

Review 1.  The evolving concept of indications for allogeneic hematopoietic cell transplantation during first complete remission of acute myeloid leukemia.

Authors:  Masamitsu Yanada
Journal:  Bone Marrow Transplant       Date:  2021-03-08       Impact factor: 5.483

Review 2.  Clonal hematopoiesis: Mutation-specific adaptation to environmental change.

Authors:  Marcus A Florez; Brandon T Tran; Trisha K Wathan; James DeGregori; Eric M Pietras; Katherine Y King
Journal:  Cell Stem Cell       Date:  2022-06-02       Impact factor: 25.269

3.  Screening a Targeted Panel of Genes by Next-Generation Sequencing Improves Risk Stratification in Real World Patients with Acute Myeloid Leukemia.

Authors:  Sónia Matos; Paulo Bernardo; Susana Esteves; Aida Botelho de Sousa; Marcos Lemos; Patrícia Ribeiro; Madalena Silva; Albertina Nunes; Joana Lobato; Maria de Jesus Frade; Maria Gomes da Silva; Sérgio Chacim; José Mariz; Graça Esteves; João Raposo; Ana Espadana; José Carda; Pedro Barbosa; Vânia Martins; Maria Carmo-Fonseca; Joana Desterro
Journal:  Cancers (Basel)       Date:  2022-06-30       Impact factor: 6.575

4.  The Impact of DNMT3A Status on NPM1 MRD Predictive Value and Survival in Elderly AML Patients Treated Intensively.

Authors:  Heiblig Maël; Duployez Nicolas; Marceau Alice; Lebon Delphine; Goursaud Laure; Plantier Isabelle; Stalnikiewich Laure; Cambier Nathalie; Balsat Marie; Fossard Gaëlle; Labussière-Wallet Hélène; Barraco Fiorenza; Ducastelle-Lepretre Sophie; Sujobert Pierre; Huet Sarah; Hayette Sandrine; Ghesquières Hervé; Thomas Xavier; Preudhomme Claude
Journal:  Cancers (Basel)       Date:  2021-04-29       Impact factor: 6.639

5.  Gene expression profiling identifies FLT3 mutation-like cases in wild-type FLT3 acute myeloid leukemia.

Authors:  Adrián Mosquera Orgueira; Andrés Peleteiro Raíndo; Miguel Cid López; Beatriz Antelo Rodríguez; José Ángel Díaz Arias; Roi Ferreiro Ferro; Natalia Alonso Vence; Ángeles Bendaña López; Aitor Abuín Blanco; Laura Bao Pérez; Paula Melero Valentín; Marta Sonia González Pérez; Claudio Cerchione; Giovanni Martinelli; Pau Montesinos Fernández; Manuel Mateo Pérez Encinas; José Luis Bello López
Journal:  PLoS One       Date:  2021-02-16       Impact factor: 3.752

6.  Diagnostic and therapeutic pitfalls in NPM1-mutated AML: notes from the field.

Authors:  Brunangelo Falini; Sofia Sciabolacci; Lorenza Falini; Lorenzo Brunetti; Maria Paola Martelli
Journal:  Leukemia       Date:  2021-04-20       Impact factor: 12.883

7.  Delineation of Molecular Lesions in Acute Myeloid Leukemia Patients at Diagnosis: Integrated Next Generation Sequencing and Cytogenomic Studies.

Authors:  Sorina Mihaela Papuc; Alina Erbescu; Diana Cisleanu; Diana Ozunu; Cristina Enache; Ion Dumitru; Elena Lupoaia Andrus; Mihaela Gaman; Viola Maria Popov; Maria Dobre; Oana Stanca; Silvana Angelescu; Nicoleta Berbec; Andrei Colita; Ana-Maria Vladareanu; Horia Bumbea; Aurora Arghir
Journal:  Genes (Basel)       Date:  2021-05-30       Impact factor: 4.096

8.  Epigenetic landscape analysis of lncRNAs in acute myeloid leukemia with DNMT3A mutations.

Authors:  Yu-Jun Dai; Fang Hu; Si-Yuan He; Yue-Ying Wang
Journal:  Ann Transl Med       Date:  2020-03

9.  Venetoclax combines synergistically with FLT3 inhibition to effectively target leukemic cells in FLT3-ITD+ acute myeloid leukemia models.

Authors:  Raghuveer Singh Mali; Qi Zhang; Rosa Anna DeFilippis; Antonio Cavazos; Vinitha Mary Kuruvilla; Jayant Raman; Vidhi Mody; Edna F Choo; Monique Dail; Neil P Shah; Marina Konopleva; Deepak Sampath; Elisabeth A Lasater
Journal:  Haematologica       Date:  2021-04-01       Impact factor: 9.941

Review 10.  3+7 Combined Chemotherapy for Acute Myeloid Leukemia: Is It Time to Say Goodbye?

Authors:  Kenny Tang; Andre C Schuh; Karen Wl Yee
Journal:  Curr Oncol Rep       Date:  2021-08-04       Impact factor: 5.075

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.